Novosphingobiumand its potential role in chronic obstructive pulmonary diseases: Insights from microbiome studies

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Rutebemberwa, Alleluiah ^a   Stevens, Mark J ^b   Perez, Mario J ^a   Smith, Lynelle P ^a   Sanders, Linda ^a   Cosgrove, Gregory ^a   Robertson, Charles E ^a   Tuder, Rubin M ^a   Harris, J Kirk ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; SMALL SUBUNIT RIBOSOMAL RNA; SMOKE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL INFECTION; BACTERIAL LOAD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION OF THE LUNGS, BRONCHI AND PLEURA; LUNG INJURY; LUNG MICROBIOME; MACROPHAGE; MALE; MICROBIOME; MIDDLE AGED; MOUSE; NEUTROPHIL COUNT; NONHUMAN; NOVOSPHINGOBIUM; NOVOSPHINGOBIUM PANIPATENSE; POLYMERASE CHAIN REACTION; RNA GENE; SPHINGOMONADACEAE; ADVERSE EFFECTS; ALPHAPROTEOBACTERIA; ANIMAL; C57BL MOUSE; CELL SEPARATION; DNA SEQUENCE; FLOW CYTOMETRY; INFLAMMATION; ISOLATION AND PURIFICATION; LUNG; LUNG LAVAGE; METABOLISM; MICROBIOLOGY; MICROFLORA; NEUTROPHIL; PATHOGENICITY; PATHOPHYSIOLOGY; SMOKE; SMOKING;

ADULT; AGED; ALPHAPROTEOBACTERIA; ANIMALS; BRONCHOALVEOLAR LAVAGE; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; LUNG; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICROBIOTA; MIDDLE AGED; NEUTROPHILS; POLYMERASE CHAIN REACTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEQUENCE ANALYSIS, DNA; SMOKE; SMOKING;

EID: 84908565968     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111150     Document Type: Article

References (57)

1. Human Microbiome Project website. Available: http://commonfund.nih.gov/hmp Human Microbiome Project. Accessed 2014 Oct 1.
2. Harris JK, De Groote MA, Sagel SD, Zemanick ET, Kapsner R, et al. (2007) Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci U S A 104: 20529-20533.
3. Zemanick ET, Sagel SD, Harris JK (2011) The airway microbiome in cystic fibrosis and implications for treatment. Curr Opin Pediatr 23: 319-324.
4. Field TR, Sibley CD, Parkins MD, Rabin HR, Surette MG (2010) The genus Prevotella in cystic fibrosis airways. Anaerobe 16: 337-344.
5. Blainey PC, Milla CE, Cornfield DN, Quake SR (2012) Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis. Sci Transl Med 4: 153ra130.
6. Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, et al. (2012) Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491: 254-258.
7. Telle O, Winogradsky Y, editors. MetaHIT. INRA - MICA Division. Available: http://www.metahit.eu. Accessed 2014 Oct 1.
8. Proctor LM (2011) The Human Microbiome Project in 2011 and beyond. Cell Host Microbe 10: 287-291.
9. Sethi S (2000) Bacterial infection and the pathogenesis of COPD. Chest 117: 286S-291S.
10. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, et al. (2004) characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 42: 5176-5183.
11. Huang YJ, Charlson ES, Collman RG, Colombini-Hatch S, Martinez FD, et al. (2013) The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report. Am J Respir Crit Care Med 187: 1382-1387.
12. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, et al. (2011) Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One 6: e16384.
13. Baughman RP, Thorpe JE, Staneck J, Rashkin M, Frame PT (1987) Use of the protected specimen brush in patients with endotracheal or tracheostomy tubes. Chest 91: 233-236.
14. Huang YJ, Lynch SV (2011) The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications. Expert Rev Respir Med 5: 809-821.
15. Han MK, Huang YJ, Lipuma JJ, Boushey HA, Boucher RC, et al. (2012) Significance of the microbiome in obstructive lung disease. Thorax 67: 456-463.
16. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, et al. (2010) Disordered microbial communities in asthmatic airways. PLoS One 5: e8578.
17. Morris A, Beck JM, Schloss PD, Campbell TB, Crothers K, et al. (2013) Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med 187: 1067-1075.
18. National Heart, Lung, and Blood Institute (2000) COPD: Are You at Risk?.
19. Mannino DM, Kiriz VA (2006) Changing the burden of COPD mortality. Int J Chron Obstruct Pulmon Dis 1: 219-233.
20. Wedzicha JA, Seemungal TA (2007) COPD exacerbations: defining their cause and prevention. Lancet 370: 786-796.
21. Pauwels RA, Rabe KF (2004) Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364: 613-620.
22. Martinez FJ (2007) Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4: 647-658.
23. MacIntyre N, Huang YC (2008) Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5: 530-535.
24. Ball P (1995) Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest 108: 43S-52S.
25. Veeramachaneni SB, Sethi S (2006) Pathogenesis of bacterial exacerbations of COPD. COPD 3: 109-115.
26. Murphy TF (2006) The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease. Curr Opin Infect Dis 19: 225-230.
27. Wedzicha JA, Seemungal TA, MacCallum PK, Paul EA, Donaldson GC, et al. (2000) Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost 84: 210-215.
28. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, et al. (2001) Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164: 1618-1623.
29. Sapkota AR, Berger S, Vogel TM (2010) Human pathogens abundant in the bacterial metagenome of cigarettes. Environ Health Perspect 118: 351-356.
30. Retamales I, Elliott WM, Meshi B, Coxson HO, Pare PD, et al. (2001) Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 164: 469-473.
31. Cosio MG, Saetta M, Agusti A (2009) Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 360: 2445-2454.
32. Nadkarni MA, Martin FE, Jacques NA, Hunter N (2002) Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148: 257-266.
33. Hamady M, Walker JJ, Harris JK, Gold NJ, Knight R (2008) Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex. Nat Methods 5: 235-237.
34. Harris JK, Sahl JW, Castoe TA, Wagner BD, Pollock DD, et al. (2010) Comparison of normalization methods for construction of large, multiplex amplicon pools for next-generation sequencing. Appl Environ Microbiol 76: 3863-3868.
35. Zemanick ET, Harris JK, Wagner BD, Robertson CE, Sagel SD, et al. (2013) Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations. PLoS One 8: e62917.
36. Frank DN (2009) BARCRAWL and BARTAB: software tools for the design and implementation of barcoded primers for highly multiplexed DNA sequencing. BMC Bioinformatics 10: 362.
37. Haas BJ, Gevers D, Earl AM, Feldgarden M, Ward DV, et al. (2011) Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res 21: 494-504.
38. Wang Q, Garrity GM, Tiedje JM, Cole JR (2007) Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 73: 5261-5267.
39. Robertson CE, Harris JK, Wagner BD, Granger D, Browne K, et al. (2013) Explicet: graphical user interface software for metadata-driven management, analysis and visualization of microbiome data. Bioinformatics.
40. Guerassimov A, Hoshino Y, Takubo Y, Turcotte A, Yamamoto M, et al. (2004) The development of emphysema in cigarette smoke-exposed mice is strain dependent. Am J Respir Crit Care Med 170: 974-980.
41. Rajendrasozhan S, Chung S, Sundar IK, Yao H, Rahman I (2010) Targeted disruption of NF-{kappa}B1 (p50) augments cigarette smoke-induced lung inflammation and emphysema in mice: a critical role of p50 in chromatin remodeling. Am J Physiol Lung Cell Mol Physiol 298: L197-209.
42. Yao H, Edirisinghe I, Rajendrasozhan S, Yang SR, Caito S, et al. (2008) Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice. Am J Physiol Lung Cell Mol Physiol 294: L1174-1186.
43. Yoshida T, Mett I, Bhunia AK, Bowman J, Perez M, et al. (2010) Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema. Nat Med 16: 767-773.
44. Rangasamy T, Cho CY, Thimmulappa RK, Zhen L, Srisuma SS, et al. (2004) Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 114: 1248-1259.
45. Mattner J, Savage PB, Leung P, Oertelt SS, Wang V, et al. (2008) Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 3: 304-315.
46. Kaplan MM (2004) Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis. Am J Gastroenterol 99: 2147-2149.
47. Shi T, Fredrickson JK, Balkwill DL (2001) Biodegradation of polycyclic aromatic hydrocarbons by Sphingomonas strains isolated from the terrestrial subsurface. J Ind Microbiol Biotechnol 26: 283-289.
48. Sze MA, Dimitriu PA, Hayashi S, Elliott WM, McDonough JE, et al. (2012) The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 185: 1073-1080.
49. Huang YJ, Kim E, Cox MJ, Brodie EL, Brown R, et al. (2010) A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS 14: 9-59.
50. Cabrera-Rubio R, Garcia-Nunez M, Seto L, Anto JM, Moya A, et al. (2012) Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease. J Clin Microbiol 50: 3562-3568.
51. Pragman AA, Kim HB, Reilly CS, Wendt C, Isaacson RE (2012) The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One 7: e47305.
52. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, et al. (2011) Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 127: 372-381 e371-373.
53. Takeuchi M, Hamana K, Hiraishi A (2001) Proposal of the genus Sphingomonas sensu stricto and three new genera, Sphingobium, Novo-sphingobium and Sphingopyxis, on the basis of phylogenetic and chemotaxonomic analyses. Int J Syst Evol Microbiol 51: 1405-1417.
54. Kelley ST, Theisen U, Angenent LT, St Amand A, Pace NR (2004) Molecular analysis of shower curtain biofilm microbes. Appl Environ Microbiol 70: 4187-4192.
55. Lemaitre D, Elaichouni A, Hundhausen M, Claeys G, Vanhaesebrouck P, et al. (1996) Tracheal colonization with Sphingomonas paucimobilis in mechanically ventilated neonates due to contaminated ventilator temperature probes. J Hosp Infect 32: 199-206.
56. Ryan MP, Adley CC (2010) Sphingomonas paucimobilis: a persistent Gramnegative nosocomial infectious organism. J Hosp Infect 75: 153-157.
57. Patrone JB, Bish SE, Stein DC (2006) TNF-alpha-independent IL-8 expression: alterations in bacterial challenge dose cause differential human monocytic cytokine response. J Immunol 177: 1314-1322.